Diphtheria Agent Targets Malignant Cells
Links shared publicly online about this topic.
- 1,016total visits
Diphtheria Agent Targets Malignant Cells
View full resource at medicalnewstoday.com
Tags: Diphtheria, Cancer, Leukemia, Lymphoma, Non-Hodgkin Lymphoma, Clinical Trial
Most Recently Shared on July 17, 2010 at 1:04 pm By:
Diphtheria Agent Targets Malignant Cells http://mnt.to/3Gdz #clinicaltrials
Also Shared By:
Agent Selectively Targets Malignant B Cells In Chronic Leukemia, Study Shows
medicalcenter.osu.edu — “Agent Selectively Targets Malignant B Cells In Chronic Leukemia, Study Shows” View full resource at medicalcenter.osu.edu
Most Recently Shared on May 4, 2011 at 2:27 pm By:
Agent Selectively Targets Malignant B Cells In Chronic Leukemia, Study Shows: COLUMBUS, Ohio – A new experimenta... http://bit.ly/lI3KCJ
Agent Selectively Targets Malignant B Cells In Chronic Leukemia, Study Shows | The Ohio State Medical Center
cancer.osu.edu — “Agent Selectively Targets Malignant B Cells In Chronic Leukemia, Study Shows | The Ohio State Medical Center” View full resource at cancer.osu.edu
Most Recently Shared on May 3, 2011 at 8:34 pm By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Agent Selectively Targets Malignant B Cells In Chronic Leukemia, Study Results. http://ow.ly/4MtvZ
Agent selectively targets malignant B cells in chronic leukemia, study shows
medicalxpress.com — “A new experimental drug selectively kills the cancerous cells that cause chronic lymphocytic leukemia, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).” View full resource at medicalxpress.com
Most Recently Shared on May 3, 2011 at 2:34 pm By:
PhysOrg Health News Health News
Agent selectively targets malignant B cells in chronic leukemia, study shows http://tw.medicalxpress.com/223637678
Nanotechnology Brings Personalized Therapy One Step Closer to Reality
newswise.com — “1) Nanoscale proteomic method identifies potential biomarkers; 2) Specific isoforms of signaling proteins associated with clinical response to agents that target cancer pathways; 3) Nanoscale profiling can help distinguish malignant and non-malignant cells.” View full resource at newswise.com
Most Recently Shared on September 29, 2010 at 1:12 am By:
newswise Health Communicator and Health News
Nanotechnology Brings Personalized Therapy One Step Closer to Reality: 1) Nanoscale proteomic method identifies po... http://bit.ly/aoGAdF
Advertisement
MNT Leukemia
@mnt_leukemia
Diphtheria Agent Targets Malignant Cells http://mnt.to/3Gdz #lymphoma #leukemia
1 year ago...